This Week's Awesome Tech Stories From Around the Web (Through Sept 3)

An AI-generated Artwork's State Fair Victory Fuels Arguments Over'What Art Is' James Vincent The Verge "The rise of text-to-AI image generators has only just begun, but already, the programs are sparking heated debates about the nature of art, whether this software poses a threat to artists' livelihoods, and whether or not the companies that create these systems [owe] anything to the artists whose work their programs are trained on." A New Gene Therapy Based on Antibody Cells Is About to Be Tested in Humans Antonio Regalado MIT Technology Review "The concept is to engineer B cells so that they manufacture other proteins instead of antibodies. For [the rare inherited disease MPS-1], what's needed is an enzyme whose absence causes diverse and devastating symptoms. Patients with the illness are currently treated with weekly infusions of the missing enzyme, but it's not enough to cure the disease outright. Immusoft says it can engineer B cells to produce the enzyme instead."